Thirteen days after her first dose of AstraZeneca, Ms Lees’ family gathered around her ICU bed at Royal Prince Alfred ...

ASCO meeting showcased some of the latest developments in cancer research with AstraZeneca (AZN) headlining the event. Read ...

Plus: Annie Lamont, Robert Nelsen, Hemant Taneja and more healthtech venture capital investors on this year's Forbes Midas ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding with AstraZeneca ...

After Enhertu pioneered the HER2-low category in breast cancer treatment, AstraZeneca and Daiichi Sankyo are now hopeful that ...

C HICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with liver cancer in early ...

AstraZeneca unveiled promising data from two trials examining cancer drugs Tagrisso and Enhertu at the 2024 ASCO annual ...

AstraZeneca last week set another ambitious goal, this time with plans to nearly double its total revenue by the end of the ...

AstraZeneca reports at ASCO that its drug Tagrisso slowed down lung cancer progression for a median of several years in stage ...

AstraZeneca ( AZN -2.44%) is embarking on a fresh business plan that will see it grow significantly between now and 2030. If ...

Buying $1000 In AZN: If an investor had bought $1000 of AZN stock 5 years ago, it would be worth $2,041.26 today based on a ...